HYBOBI-MRI: Functional and Anatomical Magnetic Resonance Imaging (MRI) of Chronic Brain Injury and Hyperbaric Oxygen (HBO2) Study Subjects

Sponsor
Intermountain Health Care, Inc. (Other)
Overall Status
Completed
CT.gov ID
NCT01126515
Collaborator
Deseret Foundation (Other)
17
1
35
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate Brain MRI (Magnetic Resonance Imaging), and Brain CT (Computed Tomography) Angiogram data in subjects who participate in the "Hyperbaric Oxygen for Chronic Stable Brain Injury" (HYBOBI) study. Including information from MRI and CT studies provide information about whether hyperbaric oxygen improves brain function in subjects who have had a brain injury. Subjects will complete MR and CT scans twice during the study. The first MR and CT will be performed prior to the first hyperbaric session of the HYBOBI study, and the second will be performed within two weeks following the last hyperbaric session.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Magnetic Resonance Imaging
  • Procedure: Computed Tomography Angiography

Detailed Description

In an ongoing feasibility study (HYBOBI), brain-injured subjects are exposed to hyperbaric oxygen at 1.5 atmospheres for 60 minutes. They receive this exposure five days per week, and receive 60 total sessions. Prior to hyperbaric oxygen, these study subjects have neurologic, cognitive, and functional measures. The measures are repeated at the conclusion of 60 hyperbaric oxygen sessions, and again six months later. The goal of the HYBOBI feasibility study is to learn about these patients and determine possible hyperbaric oxygen effects, if any, to prepare for a blinded randomized controlled clinical trial.

This study adds an imaging component to the HYBOBI study, further investigating brain changes in participants. Participants will undergo Brain MRI (Magnetic Resonance Imaging) using a 3 tesla magnet, and Brain CT (Computed Tomography) Angiogram. Subjects will undergo imaging before receiving hyperbaric oxygen and within 2 weeks of completion of the 60 hyperbaric sessions.

Study Design

Study Type:
Observational
Actual Enrollment :
17 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
MRI & CT Angiogram and Hyperbaric Oxygen in Chronic Stable Brain Injury
Study Start Date :
Jul 1, 2007
Actual Primary Completion Date :
Jun 1, 2010
Actual Study Completion Date :
Jun 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Hyperbaric oxygen

In this open-label feasibility study, all subjects will receive 60 hyperbaric oxygen sessions (100% oxygen, 1.5 atmospheres absolute (atm abs), for 60 minutes), delivered daily, five days per week.

Procedure: Magnetic Resonance Imaging
Imaging of the brain without gadolinium will be performed with a 3 Tesla magnetic resonance (MR) System (Intera Achieva 3T; Philips Medical Systems). The protocol will include anatomical sequences, a diffusion tensor imaging sequence with fiber tracking, and auditory, visual, and motor functional magnetic resonance imaging (MRI).
Other Names:
  • MRI
  • fMRI
  • Procedure: Computed Tomography Angiography
    Computed tomography angiography (CTA) with intravenous (IV) contrast will be performed on a 320 head computed tomography (CT) scanner, assessing brain perfusion.
    Other Names:
  • CT
  • CTA
  • Outcome Measures

    Primary Outcome Measures

    1. Auditory functional magnetic resonance imaging (fMRI) activation [Within 2 weeks of final hyperbaric session]

      The first prime outcome measure will be auditory functional magnetic resonance imaging (fMRI) activation, comparing post-hyperbaric oxygen to pre-hyperbaric oxygen. This is a categorical variable: absent, mild, moderate, normal, and increasing. We will look at the difference between pre-hyperbaric (pre-HBO2) and post-hyperbaric (post-HBO2) scans graphically and descriptively, with the percentage of patients who show any improvement (any change towards normal).

    2. Computed tomography angiography (CTA) Brain Perfusion [Within 2 weeks of the final hyperbaric session]

      Pre-hyperbaric (pre-HBO2) computed tomography angiography (CTA) results will be determined to be normal or abnormal, and then compared to the post-hyperbaric (post-HBO2) scan, which will be scored as better, worse, or no change.

    Secondary Outcome Measures

    1. MRI Results [Within 2 weeks of the final hyperbaric session]

      Cortical activation (amount and location) for motor, visual, and olfactory fMRI. Diffusion tensor imaging (fractional anisotropy differences, number of fiber tracts) within the Corpus Callosum

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Subject has had a brain injury > 12 months

    • Subject is >18 years old

    • Etiology of brain injury:

    • stroke

    • carbon monoxide

    • anoxia

    • trauma

    • Must be able to equalize ears, or have tympanostomy tubes

    • Willingness to complete outcome measures and comply with the research protocols

    • Commitment to pay the hospital for hyperbaric oxygen

    • Subject is enrolled in Hyperbaric Oxygen and Chronic Stable Brain Injury study-clinical trials government ID# NCT00830453.

    Exclusion Criteria:
    • Glasgow Coma Score <13 at the time of consent

    • Poorly controlled seizures

    • Inability to participate in outcome assessments (eg: blindness, quadraplegia); Claustrophobia

    • Inability to equalize ears

    • Inability to protect airway, or requiring frequent suctioning

    • Tracheostomy

    • Women of child-bearing potential or currently pregnant

    • Severe psychiatric disorders

    • Taking lithium

    • Degenerative mental disease

    • Chronic debilitating disease

    • Heart failure with ejection fraction <50% or inability to lay supine

    • Active malignancy, or prior treatment with cisplatin or bleomycin

    • Current recreational drug use

    • Consumption of more than the equivalent of 12 beers/week habitually

    • Prior treatment with hyperbaric oxygen for chronic brain injury within the last year

    • Implanted device that is a contra-indication to MRI

    • Inability to travel to Las Vegas, either by car or by air

    • Serum creatinine greater than the Intermountain Central Lab normal limit

    • Unwillingness or inability to have intravenous contrast.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 LDS Hospital Salt Lake City Utah United States 84143

    Sponsors and Collaborators

    • Intermountain Health Care, Inc.
    • Deseret Foundation

    Investigators

    • Principal Investigator: Susan K Churchill, APRN-NP, Intermountain Health Care, Inc.
    • Principal Investigator: Lindell K Weaver, MD, Intermountain Health Care, Inc.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Lindell Weaver, Medical Director, Hyperbaric Medicine, Intermountain Health Care, Inc.
    ClinicalTrials.gov Identifier:
    NCT01126515
    Other Study ID Numbers:
    • 1004120
    First Posted:
    May 19, 2010
    Last Update Posted:
    Jul 29, 2020
    Last Verified:
    Jul 1, 2020
    Keywords provided by Lindell Weaver, Medical Director, Hyperbaric Medicine, Intermountain Health Care, Inc.
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 29, 2020